Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M250,368Revenue $M50,370Net Margin (%)18.7Altman Z-Score3.8
Enterprise Value $M36,905EPS $1.4Operating Margin %28.3Piotroski F-Score5
P/E(ttm)25.3Beneish M-Score-2.8Pre-tax Margin (%)25.1Higher ROA y-yN
Price/Book11.910-y EBITDA Growth Rate %4.7Quick Ratio1.0Cash flow > EarningsY
Price/Sales4.75-y EBITDA Growth Rate %3.8Current Ratio1.4Lower Leverage y-yN
Price/Free Cash Flow18.7y-y EBITDA Growth Rate %-14.0ROA % (ttm)14.0Higher Current Ratio y-yN
Dividend Yield %2.7PEG6.7ROE % (ttm)49.7Less Shares Outstanding y-yY
Payout Ratio %73.0Shares Outstanding M6,798ROIC % (ttm)37.6Gross Margin Increase y-yN

Gurus Latest Trades with RHHBY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
RHHBYKen Fisher 2015-03-31 Reduce$32.1 - $36.505
($34.06)
$ 36.838%Reduce 1.24%2,788,126
RHHBYKen Fisher 2014-12-31 Add0.07%$34.16 - $37.92
($36.33)
$ 36.831%Add 49.26%2,823,025
RHHBYKen Fisher 2014-06-30 Reduce-0.07%$35.42 - $38.07
($36.82)
$ 36.830%Reduce 49.71%1,813,443
RHHBYKen Fisher 2014-03-31 Add0.07%$18.14 - $38.17
($29.75)
$ 36.8324%Add 99.00%3,606,140
RHHBYKen Fisher 2013-12-31 Reduce$31.96 - $35.24
($34.15)
$ 36.838%Reduce 0.26%1,812,112
RHHBYKen Fisher 2013-09-30 Add$30.655 - $33.765
($31.86)
$ 36.8316%Add 0.28%1,816,868
RHHBYTweedy Browne 2013-06-30 Sold Out $28.92 - $32.98
($30.91)
$ 36.8319%Sold Out0
RHHBYKen Fisher 2013-06-30 Add$28.92 - $32.98
($30.91)
$ 36.8319%Add 0.90%1,811,804
RHHBYKen Fisher 2013-03-31 Add0.12%$25.615 - $29.3
($27.78)
$ 36.8333%Add 634.57%1,795,722
RHHBYKen Fisher 2012-12-31 Reduce$23.08 - $25.68
($24.53)
$ 36.8350%Reduce 14.81%244,460
RHHBYTweedy Browne 2012-12-31 Reduce$23.08 - $25.68
($24.53)
$ 36.8350%Reduce 3.04%120,548
RHHBYTweedy Browne 2012-09-30 Reduce-0.03%$20.985 - $24.07
($22.5)
$ 36.8364%Reduce 24.31%124,328
RHHBYKen Fisher 2012-09-30 Reduce$20.985 - $24.07
($22.5)
$ 36.8364%Reduce 7.27%286,946
RHHBYVanguard Health Care Fund 2012-06-30 Add2.96%$19.43 - $23.14
($21.18)
$ 36.8374%Add 543.36%8,547,954
RHHBYKen Fisher 2012-06-30 Reduce-0.01%$19.43 - $23.14
($21.18)
$ 36.8374%Reduce 24.26%309,426
RHHBYKen Fisher 2012-03-31 Reduce-1.27%$20.885 - $22.5
($21.78)
$ 36.8369%Reduce 98.02%408,552
RHHBYTweedy Browne 2012-03-31 Reduce-0.04%$20.885 - $22.5
($21.78)
$ 36.8369%Reduce 22.19%164,260
RHHBYKen Fisher 2011-12-31 Reduce-0.26%$18.31 - $21.33
($20.11)
$ 36.8383%Reduce 15.75%20,679,972
RHHBYTweedy Browne 2011-12-31 Reduce$18.31 - $21.33
($20.11)
$ 36.8383%Reduce 0.53%211,110
RHHBYTweedy Browne 2011-09-30 Buy 0.1657%$18.66 - $22.625
($20.77)
$ 36.8377%New holding212,230
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

RHHBY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


RHHBY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about RHHBY :

    Quarterly/Annual Reports about RHHBY:

      News about RHHBY:

      Articles On GuruFocus.com
      Baxter Takes The Acquisition Route To Grow In The Oncology Segment May 14 2015 
      Roche’s Oncology Drugs Drive Its Revenue Northwards In Q1 Apr 24 2015 
      Top Weighted Stocks in Tweedy Browne Global Value Fund's Portfolio Apr 22 2015 
      What Are The Intrinsic Factors Contributing To Pfizer’s Stock Movement? Mar 27 2015 
      AbbVie To Acquire Biopharmaceutical Firm Pharmacyclics Mar 06 2015 
      Small Cap Biotech Growth Stocks For 2015 Mar 05 2015 
      Can These Three BioTech Companies Make It Big? Feb 20 2015 
      Pharmaceuticals Sector To See High Voltage Action in 2015 Jan 23 2015 
      Roche In Expansion Mode Jan 19 2015 
      Why Organovo is A Safe Buy? Dec 18 2014 

      More From Other Websites
      Why Denali Raised A $217 Million Financing Round: Not Just 'Because It Could' May 21 2015
      Can Roche Win From The War On Lung Cancer? UBS Thinks So May 18 2015
      Roche Reports Encouraging Data on Lung Cancer Drugs - Analyst Blog May 14 2015
      ASCO's immunotherapies update May 14 2015
      Genentech’s Investigational Immunotherapy MPDL3280A Doubled the Likelihood of Survival Compared... May 13 2015
      Genentech’s Investigational Medicine Alectinib Shrank Tumors in Nearly Half of People With... May 13 2015
      Possible Investment Contest May 13 2015
      Xenon Pharmaceuticals Reports First Quarter 2015 Financial Results and Provides Corporate Update May 12 2015
      Xenon Pharmaceuticals Reports First Quarter 2015 Financial Results and Provides Corporate Update May 12 2015
      Pivotal Data for Genentech Medicines in Lung and Blood Cancers to Be Presented at ASCO May 11 2015
      Roche Receives FDA Approval for cobas® KRAS Mutation Test May 11 2015
      Genentech Announces New STEM Education Initiative to Support South San Francisco Schools May 04 2015
      [$$] In Battle Against Alzheimer’s, This May Be Ground Zero Apr 28 2015
      New Prenatal DNA Test For Down Syndrome Dramatically Reduces Errors Apr 26 2015
      Roche Beats on Q1 Sales driven by Oncology & Immunology - Analyst Blog Apr 23 2015
      Roche Revenue Lifted by Cancer Drugs Apr 22 2015
      Seeing price pressure in Europe: Roche CEO Apr 22 2015
      Bina Technologies and AstraZeneca Announce Collaborative Agreement for Global Deployment of Bina’s... Apr 21 2015
      OTC Markets Group Announces First Quarter 2015 Performance of OTCQX and OTCQB Indexes, OTCM ADR... Apr 16 2015
      Roche Acquires CAPP Medical to Strengthen Cancer Diagnosis - Analyst Blog Apr 14 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      Steve.dunfield@google
      ReplySteve.dunfield@google - 1 year ago
      Adjust for split?
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      FEEDBACK